News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

W. Paul Nichol, MD

Articles by W. Paul Nichol, MD

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts

ByAmy J. Grizzle, PharmD,Maysaa H. Mahmood, MS,Yu Ko, MS,John E. Murphy, PharmD,Edward P. Armstrong, PharmD,Grant H. Skrepnek, PhD,William N. Jones, MS,Gregory P. Schepers, PharmD,W. Paul Nichol, MD,Antoun Houranieh, PhD,Donna C. Dare, PharmD,Christopher T. Hoey, PharmD,Daniel C. Malone, PhD

October 1st 2007

Latest Updated Articles

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts
Published: October 1st 2007 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

How Do GLP-1 Agonists Fit Into Stroke Care?

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text